Joint Plus Tendon Spray
NDC Package 50845-0273-1
Package Information
Joint Plus Tendon (aconitum napellus, apis mellifica, arnica montana, cartilago suis, hydrastis canadensis, hypericum perforatum, rhus tox, thuja occidentalis) sprays May temporarily ease discomfort associated with inflammation of joints, tendons and nerves.****Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a spray delivery system. Marketed by Liddell Laboratories, Inc., this product is identified by NDC 50845-0273.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50845 - Liddell Laboratories, Inc.
- 50845-0273 - Joint Plus Tendon
- 50845-0273-1 - 30 mL in 1 BOTTLE, SPRAY
- 50845-0273 - Joint Plus Tendon
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50845-0273-1 identifies a specific commercial package of 30 ml in 1 bottle, spray of Joint Plus Tendon, a human over the counter drug labeled by Liddell Laboratories, Inc.. This spray is formulated for oral use and contains aconitum napellus whole; apis mellifera; arnica montana whole; goldenseal; hypericum perforatum whole; sus scrofa cartilage; thuja occidentalis leafy twig; toxicodendron pubescens leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Liddell Laboratories, Inc. on June 20, 2022. The current certification is valid through December 31, 2026.
How is this Liddell Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50845027301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.